Nonsurgical cure of isolated cerebral mucormycosis in an intravenous drug user

Eur J Clin Microbiol Infect Dis. 1996 Jul;15(7):598-9. doi: 10.1007/BF01709370.

Abstract

The case of a 30-year-old, female, HIV-positive intravenous drug user who suffered from isolated cerebral mucormycosis is reported. Treatment with amphotericin B at an accumulative dose of 5.5 grams led to significant recovery, and there was no recurrence of disease over a follow-up period of six months. Patients with isolated cerebral mucormycosis in whom surgery would be a high-risk or impossible procedure could be managed medically with prolonged courses of intravenous amphotericin B.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B / administration & dosage
  • Amphotericin B / therapeutic use*
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use*
  • Brain / microbiology
  • Brain / pathology
  • Female
  • HIV Infections / complications*
  • Humans
  • Mucormycosis / diagnostic imaging
  • Mucormycosis / drug therapy*
  • Radiography
  • Substance Abuse, Intravenous / complications
  • Substance Abuse, Intravenous / microbiology
  • Substance Abuse, Intravenous / virology

Substances

  • Antifungal Agents
  • Amphotericin B